DataMEDS AI Buys Helomics Cancer Lab And CRO Assets As Shares Jump 170% In Pre-Market

DataMEDS AI (MEDS), a precision medicine and AI-driven healthcare company, has acquired the Helomics AI cancer diagnostics laboratory and precision oncology contract research organization businesses from Axe Compute (AGPU), marking a strategic expansion into AI-powered cancer profiling and drug development services.